Validation Study on the Removal of EpCAM-positive Tumour Cells From Blood Collected During Tumour Surgery Using Catumaxomab/Catuvab Device

Clinical trial NCT06789224 · COMPLETED

Trial details

NCT number: NCT06789224
Sponsor: Lindis Bloodcare GmbH
Status: COMPLETED
Phase: Not Applicable
Study type: INTERVENTIONAL

Bladder Carcinoma Prostate Tumor Gallbladder Carcinoma Endometrial Carcinoma Gastric Carcinoma Ovarian Carcinoma Pancreatic Carcinoma Colon Carcinoma Non-small Cell Lung Cancer Peritoneal Carcinomatosis Kidney Carcinoma Liver Carcinoma

Start date: 2022-02-15
Primary completion: 2023-11-25
Enrollment: 136

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.